Mossman, David

Demethylation by 5-aza-2'-deoxycytidine in colorectal cancer cells targets genomic DNA whilst promoter CpG island methylation persists. [electronic resource] - BMC cancer Jul 2010 - 366 p. digital

Publication Type: Journal Article; Research Support, Non-U.S. Gov't

1471-2407

10.1186/1471-2407-10-366 doi


Acetylation
Apoptosis
Azacitidine--analogs & derivatives
Biomarkers, Tumor--genetics
Blotting, Western
Cell Proliferation
Cells, Cultured
Colorectal Neoplasms--drug therapy
CpG Islands
DNA Methylation
DNA Modification Methylases--antagonists & inhibitors
DNA, Neoplasm--genetics
Decitabine
Enzyme Inhibitors--pharmacology
Epigenesis, Genetic
Fibroblasts--cytology
Gene Expression Profiling
Gene Expression Regulation, Neoplastic--drug effects
Genome, Human
Histone Deacetylase Inhibitors--pharmacology
Histone Deacetylases--chemistry
Histones--metabolism
Humans
Hydroxamic Acids--pharmacology
Immunoenzyme Techniques
Oligonucleotide Array Sequence Analysis
Promoter Regions, Genetic--genetics
RNA, Messenger--genetics
Reverse Transcriptase Polymerase Chain Reaction